key: cord-0813940-5v93qst1
authors: Sami, Ramin; Hajian, Mohammad-Reza; Amra, Babak; Soltaninejad, Forogh; Mansourian, Marjan; Mirfendereski, Sam; Sadegh, Raheleh; Khademi, Nilufar; Jalali, Soheila; Shokri-Mashhadi, Nafiseh
title: Risk Factors for the Mortality in Hospitalized Patients with COVID-19: A Brief Report
date: 2021-11-03
journal: Iran J Med Sci
DOI: 10.30476/ijms.2021.47835
sha: 3253474feb3a7e3e6f0dafc78b808332923f50a0
doc_id: 813940
cord_uid: 5v93qst1

The cumulative rate of death of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has necessitated better recognizing the risk factors of the disease and the COVID-19-induced mortality. This cross-sectional study aimed to determine the potential risk factors that predict COVID-19-related mortality concentrating on the initial recorded laboratory tests. We extracted admission’s medical records of a total of 136 deaths related to COVID-19 and 272 discharged adult inpatients (≥18 years old) related to four referral centers from February 24(th) to April 12(th), 2020, in Isfahan, Iran, to figure out the relationship between the laboratory findings and mortality beyond demographic and clinical findings. We applied the independent sample t test and a chichi square test with SPSS software to compare the differences between the survivor and non-survivor patients. A P value of less than 0.05 was considered significant. Our results showed that greater length of hospitalization (P≤0.001), pre-existing chronic obstructive pulmonary disease (P≤0.001), high pulse rate, hypoxia (P≤0.001), and high computed tomography scan score (P<0.001), in addition to high values of some laboratory parameters, increase the risk of mortality. Moreover, high neutrophil/lymphocyte ratio (OR, 1.890; 95% CI, 1.074-3.325, P=0.027), increased creatinine levels (OR, 15.488; 95% CI, 0.801-299.479, P=0.07), and elevated potassium levels (OR, 13.400; 95% CI, 1.084-165.618, P=0.043) independently predicted in-hospital death related to COVID-19 infection. These results emphasized the potential role of impaired laboratory parameters for the prognosis of fatal outcomes in adult inpatients.

The increasing growth of COVID-19related mortality has highlighted the need to recognize the risk factors associated with severe COVID-19 infection.

• Recent epidemiological studies have investigated the relationship between various risk factors and the fatal risk of COVID- 19. • There is a lack of well-documented data regarding the association between impaired laboratory parameters and mortality risks related to COVID-19 infection.

What's New • We identified certain clinical risk factors, including a history of chronic obstructive pulmonary disease COPD, hypoxia during hospitalization, and initial computed tomography scan (CT) scores, which independently increase the odds of COVID-19-related mortality. • We provided an independent COVID-19-related mortality prediction model based on the initial recorded laboratory tests on the data of multicenter hospitals.

The outbreak of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a threat to global public health. 1 In general, due to the rapid spread of COVID-19 through human-to-human communication, the prevalence is currently on an increasing trend. In this regard, the WHO's latest global data recorded, as of 14 March 2021, just about 141.5 million confirmed cases of COVID-19. 2 Additionally, recent statistics determined that in the Middle East, a high death rate of COVID-19 cases was observed in Iran (58.61%) and Turkey (30.86%). 3 Furthermore, The COVID-19 epidemic model predicted mortality of 11.7% of in-hospital mortality in patients with COVID-19 using a casecontrol study in Isfahan. 4, 5 These outcomes highlighted the need to better recognize the risk factors associated with severe COVID-19 infection. 6 Recently, studies have specified that the average COVID-19-related deaths have been found in the older population and male gender. 7 Additionally, released epidemiological data by the Centers of Disease Control and Prevention (CDC) has revealed that several pre-existing comorbidities, including cardiovascular disease, hypertension, diabetes, respiratory disease, and cancers, are related to increased fatality risk. 8 In addition to the clinical and epidemiological characteristics, fluctuations in laboratory parameters are recently reported in COVID-19 to affect patients and have worse outcomes. 9 However, limited data are focusing on laboratory parameters beyond the epidemiology and clinical features of patients in the prognosis of COVID-19-related mortality.

This short report aimed to determine the potential risk factors that predict COVID-19related mortality concentrating on the initial recorded laboratory tests based on the data of multi-center population-based cohort study.

This cross-sectional study was conducted to determine the potential risk factors that predict COVID-19-related mortality. Therefore, we obtained the medical recorded information of 136 death cases caused by COVID-19 (≥18 years old) related to four referral centers from February 24 th to April 12 th , 2020, in Isfahan, Iran. To determine the relationship between the demographic, clinical, and laboratory findings and mortality, we analyzed the medical information of 272 discharged inpatients and compared it 

We utilized an independent sample t test for continuous data and a Chi square test for categorical data to compare the differences between the survivor and non-survivor patients considering a P value<0.05 as statistically significant using SPSS (IBM SPSS Statistics 20.0). Continuous and categorical variables were presented as mean±SD and number (%), respectively. Univariable and multivariable logistic regression models were employed to explore the potential risk factors associated with mortality. To analyze the association between the laboratory findings with mortality in patients affected by COVID-19, we categorized these according to previous studies. Table 1 represents the details of baseline characteristics of survivor (n=272) and nonsurvivor patients (n=136). A total of 408 cases (210 women and 198 men) were included in this study. Compared with the survived patients, those who experienced death were 55-70 years (P<0.001) and men (P<0.001). They also tended to have a higher mean length of patients' hospital stay (P<0.001) and a long duration of symptoms onset, the average duration of hospital admission until (P=0.005) . Moreover, univariate analysis identified that comorbidities, including hypertension (P<0.001), diabetes (P<0.001), COPD (P<0.001), chronic kidney disease (P=0.007), heart failure (P=0.013), and hyperlipoproteinemia (P=0.024) were significantly different between the two groups. These results are in accordance with those derived from a previous study, which might be on account of the higher prevalence of medical problems in the mentioned disease. 6 Having dyspnea (P<0.001), diarrhea (P<0.001), and chills (P<0.001) were the main clinical death-related symptoms. Furthermore, some laboratory findings and global CT scores remained significantly different between the two groups. As presented in table 2, the logistic model indicated that a history of COPD, hypoxia, and CT scores increased the odds of COVID-19 mortality. In the multivariate analysis, we also observed that pre-existing pulmonary disease was associated with the risk of mortality.

Regarding laboratory data, we found the influential role of neutrophil/ lymphocyte ratio, serum blood urea nitrogen (BUN) creatinine, alanine transaminase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), sodium, potassium, calcium, and phosphorus levels on the risk of mortality (table 3) , in addition to other clinical characteristics. Furthermore, our investigation showed a significant relationship between low hemoglobin concentrations and mortality. The multivariate predictive model also indicated that high neutrophil/ lymphocyte ratio (OR, 1.890; 95% CI, 1.074-3.325, P=0.027), increased creatinine levels (OR, 15.488; 95% CI, 0.801-299.479, P=0.07), and elevated potassium levels (OR, 13.400; 95% CI, 1.084-165.618, P=0·043) are independent risk factors of the fatality of COVID-19 (table 3) .

The present study initially identified that a history of COPD, hypoxia, and CT scores increase the odds of COVID-19 mortality related to COVID-19 infection. However, unlike previous reports, [11] [12] [13] our multivariate analysis showed that only pre-existing pulmonary disease was associated with the risk of mortality. This result may be attributed to further adjustment for potential confounders. 14 We also indicated the risk of mortality accompanied by other clinical characteristics, similar to the previous papers. [15] [16] [17] As suggested by Chan and colleagues, patients with high creatinine, BUN, and potassium levels had a higher odds ratio (OR) of COVID-19 mortality. 18 Additionally, our investigation revealed the significant relationship between low hemoglobin concentrations and mortality for the first time. We assumed that this result might be owing to the critical role of hemoglobin in carrying oxygen. 19 Further analysis in our study indicated the raised neutrophil/ lymph ratio, creatinine, and elevated potassium levels as independent risk factors of the fatality of COVID-19 (table 2) , due to neutrophils' role in the innate immune response and the dose-dependent relationship between acute kidney injury (AKI) stages and death. 16, 20 Despite numerous strengths of our study, certain limitations should be noted; our comparison relied on inpatients' data. There were possibly some cases that were not hospitalized, and the information in our study was related to only those who required medically attended care. Therefore, the community-based study of patients infected with COVID-19 is needed to confirm our results.

This report indicated that a high neutrophil/ lymphocyte ratio, increased creatinine levels, and elevated potassium levels could independently predict mortality induced by COVID-19. These results emphasized the potential role of impaired laboratory parameters for the prognosis of fatal outcomes and their practical benefits regarding their ability to be used for the prognosis of fatal outcomes in adults with COVID-19. Our findings could also assist clinicians to recognize patients with a poor prognosis. 

WHO Director-General's opening remarks at the media briefing on COVID-19

COVID-19 weekly epidemiological update

The prevalence study of coronavirus disease (Covid-19) cases in Asia

Model Prediction for In-Hospital Mortality in Patients with COVID-19: A Case-Control Study in Isfahan, Iran

Forecasting Covid-19 epidemic in Isfahan using a dynamic modeling approach

Factors associated with COVID-19-related death using OpenSAFELY

Epidemiological features and hotspot of COVID-19 in Isfahan province of Iran: Results of a cohort study

Clinical determinants for fatality of 44,672 patients with COVID-19

Novel coronavirus disease 2019: predicting prognosis with a computed tomography-based disease severity score and clinical laboratory data

Real-time RT-PCR for COVID-19 diagnosis: challenges and prospects

Association of cardiovascular disease and 10 other preexisting comorbidities with COVID-19 mortality: A systematic review and meta-analysis

Pre-existing COPD is associated with an increased risk of mortality and severity in COVID-19: a rapid systematic review and meta-analysis

Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. The lancet Respiratory medicine

Sensitivity Analysis in Observational Research: Introducing the E-Value

Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection

Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross-sectional study

Effects of select dietary supplements on the prevention and treatment of viral respiratory tract infections: a systematic review of randomized controlled trials

Acute Kidney Injury in Hospitalized Patients with COVID-19

Association of Hemoglobin Concentration and Its Change With Cardiovascular and All-Cause Mortality

The role of neutrophils in immune dysfunction during severe inflammation

We thank the Vice-Chancellor in the research affairs of Isfahan University of Medical Sciences for the financial support (grant number: 199003).Conflict of Interest: None declared.